Core Viewpoint - The company, Haijia Medical, announced a share buyback program due to its stock price not reflecting its intrinsic value or business prospects, committing to repurchase shares for at least RMB 300 million [1] Group 1: Share Buyback Announcement - On December 15, Haijia Medical disclosed its intention to buy back shares, stating that the current trading price does not reflect its intrinsic value [1] - The company executed its first buyback on December 17, purchasing approximately 493,800 shares for about HKD 6.0098 million [1] Group 2: Market Performance and Sentiment - On December 12, Haijia Medical's stock hit a year-low of HKD 11.33, indicating a downward trend away from the 5-day moving average [3] - Following the buyback announcement, the stock price rose by 3.27% on December 16, although it showed signs of selling pressure with a significant increase in trading volume [6][9] - The trading volume on December 16 surged to 11.5494 million shares, a 152.05% increase from the previous day, indicating a shift in market sentiment [6] Group 3: Financial Performance and Valuation - Haijia Medical's mid-year report indicated a decline in revenue from inpatient services by 18.4% year-on-year, while outpatient services saw a decrease of 11.2% [10] - The company reported stable patient visits at 2.2 million, suggesting that demand for its services remains unaffected despite revenue fluctuations [10] - The company's capital expenditure has decreased by 28.5% to RMB 242 million, indicating a shift towards mergers and acquisitions rather than new hospital constructions [11] Group 4: Valuation Comparison - Haijia Medical's price-to-earnings (PE) ratio stands at 15.71, which is below the industry average of 17, suggesting that the company is undervalued compared to its peers [12]

Core Viewpoint - The company, Haijia Medical, announced a share buyback program due to its stock price not reflecting its intrinsic value or business prospects, committing to repurchase shares for at least RMB 300 million [1]. Group 1: Share Buyback Announcement - On December 15, Haijia Medical disclosed its intention to buy back shares, stating that the current trading price does not reflect its intrinsic value [1]. - The company executed its first buyback on December 17, purchasing approximately 493,800 shares for about HKD 6.0098 million [1]. Group 2: Market Performance Analysis - On December 12, Haijia Medical's stock hit a year-low of HKD 11.33, indicating a downward trend away from the 5-day moving average [3]. - Since August 1, the stock has been in a downtrend, with a significant drop following a profit warning, leading to low trading volumes [3][5]. - The stock's highest price on December 12 was HKD 11.61, which was below the lower Bollinger Band of HKD 11.64, indicating an oversold condition [3]. Group 3: Trading Volume and Market Sentiment - Following the buyback announcement, trading volume increased significantly, with a notable rise in daily average volume, indicating a shift in market sentiment [5][8]. - On December 16, the stock rose by 3.27% but showed signs of selling pressure, with trading volume increasing by 152.05% compared to the previous day [5][6]. Group 4: Financial Performance and Valuation - Haijia Medical's mid-year report indicated a decline in revenue for inpatient and outpatient services, with inpatient revenue at RMB 1.22 billion (down 18.4% year-on-year) and outpatient revenue at RMB 722 million (down 11.2% year-on-year) [9]. - The company reported stable patient visits at 2.2 million, suggesting demand for its services remains unaffected despite revenue declines [9]. - The company is optimizing capital allocation, with a decrease in capital expenditures to RMB 242 million, down 28.5% year-on-year, and plans to focus on acquisitions rather than new hospital constructions [10]. Group 5: Industry Valuation Context - Haijia Medical's price-to-earnings (PE) ratio stands at 15.71, significantly lower than the industry average of 17, indicating a potential undervaluation compared to peers [11].

随着人口老龄化程度不断加深，老年群体的医疗康养需求日益多元，医疗机构正积极探索更优质的服务 路径。江苏省南通市第三人民医院（南通市老年病医院）深耕老年医疗领域多年，将智慧科技与人文关 怀深度融合，形成了一套独具特色的老年康养服务模式，为老年患者提供全方位、全周期的医疗照护。 走进医院"三院长青园"老年医学科，暖色调环境搭配细节满满的适老设计，让病房充满家的温馨。墙面 90厘米高扶手、卫生间防滑设施、紧急呼叫系统触手可及，水果标识的病房门方便阿尔茨海默症患者识 别，转角防撞软包与走廊休息座椅全方位守护安全。 医院打破传统治疗模式，构建"评估—干预—康复—延续"全周期服务体系。引入步态平衡操、手部功能 康复系统，设计阶梯式康复计划，开展吞咽障碍集束化训练，助力老人恢复身体功能。病房内的读书 角、回忆墙与老年活动室丰富精神生活，每周举办的记忆工作坊、方言健康讲堂、康复趣味赛等特色活 动，让康养过程更具温度。 82岁的周爷爷，住院期间因子女无法陪护，陷入低落情绪。护理团队通过倾听式沟通、搭建云端亲情 桥、举办生日会等举措，让老人重拾生活热情，积极配合治疗并顺利康复。 针对老年人"一人多病、病情复杂"的特点，医院打造多 ...

转自：贵州日报 在清镇市妇幼保健院的专家诊室里，常能见到冯骥的身影。这份为患者守护健康的坚守，已在她的职业 生涯中延续了三十余载。 作为深耕医疗健康领域30余年的妇产科主任医师，她退休后仍返聘坚守专家门诊，以精湛医术守护群众 健康；作为执掌医院管理工作的副院长，她以专业视角统筹医疗资源，推动医疗服务提质增效；作为市 人大代表，她秉持"专业为桥、民生为根"的信念，在妇幼健康保障、人口发展促进等领域积极履职，当 好群众的"贴心人"。她就是贵阳市第十五届人大代表、清镇市市管专家、清镇市妇幼保健院原副院长冯 骥。 作为连续三届贵阳市人大代表，冯骥始终将这句誓言践行在履职的每一步。为了摸清基层民生的真实需 求，她的足迹踏遍清镇市9个乡镇街道。村卫生室的诊疗桌前、乡镇卫生院的病房里、农户家中的板凳 上，都留下了她调研走访的身影。 以医者仁心守护患者健康 2025年5月退休后，面对医院的诚意返聘，冯骥毫不犹豫地应允，还主动提出将周日纳入坐诊安排。"很 多女性平时要上班，请假看病会耽误工作，周末就诊对她们来说更方便。"一句朴实的话语，满含着冯 骥对患者的深切关怀。 这份关怀根植于家庭传承。"我的父亲是医生，他一辈子都和病人站 ...

Core Viewpoint - The inauguration of the Suzhou Hospital of the China Academy of Chinese Medical Sciences marks a significant step in enhancing traditional Chinese medicine resources in the Yangtze River Delta region [1] Group 1: Hospital Overview - The Suzhou Hospital is a collaboration between the Suzhou government and the China Academy of Chinese Medical Sciences, designed as a tertiary public traditional Chinese medicine hospital [1] - The hospital is planned to have 1,000 beds, with an initial opening of 340 beds, aiming to attract top traditional Chinese medicine talent [1] Group 2: Medical Services and Specialties - The hospital's departments cover multiple disciplines, including internal medicine (cardiology, pulmonary diseases, gastrointestinal diseases) and surgery (general surgery, vascular surgery), as well as other specialties like orthopedics, proctology, and gynecology [1] - The hospital provides comprehensive diagnosis and treatment services, addressing both common and complex medical conditions [1] Group 3: Operational Status and Achievements - Since the outpatient trial operation began on November 26 and the full opening of emergency and inpatient services on December 10, the hospital has achieved stable and orderly operations [1] - The establishment of the Qihuang Scholar Studio, featuring scholars from the China Academy of Chinese Medical Sciences, aims to enhance regional traditional Chinese medicine diagnosis and research capabilities [1] Group 4: Research and Development - The unveiling of the Suzhou branch of the National Clinical Research Center for Traditional Chinese Medicine in Cardiology within the hospital is intended to promote collaborative research and the translation of results in the field of traditional Chinese medicine for cardiovascular diseases [1]

2025年的冬至（12月21日），上百万网友等待着宁波"小洛熙"医疗纠纷的后续——两天前的晚上，"小洛熙爸爸"在社交媒体上再度发文，质 疑其5月龄女儿手术的合理性和规范性。 20日，该博文被公众人物转发，在网络上引发大量评论；同日下午5点许，宁波市卫健委工作人员回应媒体采访，称正在进行医疗事故鉴定 后续程序，尸检报告将予以考量，后续将依据医疗事故鉴定结果对涉事责任医师作出处理；当晚9点后，多家媒体报道医院就患儿部分尸检 报告发布情况说明，但一个小时后，许多人发现"宁波大学附属妇女儿童医院"微信公众号的相关文章已不见踪影。 12月21日，《每日经济新闻》记者拨打了宁波市卫健委的公开及24小时值班热线，并联系了宁波大学附属妇女儿童医院宣传科，但上述电话 均无人接听。 这次医疗事件的真相是什么？责任如何厘定？又是谁说了算？12月21日，《每日经济新闻》记者采访了医院管理人员、资深临床医生、医疗 纠纷律师和社工服务机构，还原出一条医疗事故责任认定的规范路径。 医院管理人士：我"理解"医院的沉默 2025年11月14日，宁波5月龄早产儿"小洛熙"在宁波大学附属妇女儿童医院接受心脏房间隔缺损手术后离世。 据媒体报道，"小 ...

Core Viewpoint - The establishment of the Zhejiang University School of Medicine Affiliated Shao Yifu Hospital Xinjiang Production and Construction Corps Aral Hospital as the first national regional medical center in the Corps aims to enhance healthcare services in southern Xinjiang, addressing diverse medical needs of local workers and communities [10][11]. Group 1: Medical Center Functions and Services - The national regional medical center integrates functions such as medical care, education, research, health care, rehabilitation, and emergency services, focusing on minimally invasive techniques, critical care for respiratory diseases, oncology, and emergency medical rescue [10]. - The hospital utilizes the "Internet + Medical" model to enhance service delivery, allowing patients to access quality healthcare with reduced travel [4][5]. Group 2: Collaboration and Resource Sharing - The hospital collaborates with Zhejiang University to leverage high-quality medical resources, enhancing training and talent development for the national regional medical center [7][19]. - A three-tiered medical service network has been established, integrating the national regional medical center, branch hospitals, and grassroots health facilities to improve healthcare accessibility [13]. Group 3: Technological Integration and Innovation - The hospital employs advanced technologies such as 5G, big data, and artificial intelligence to create a remote medical network, expanding its reach and improving collaborative efficiency [13]. - The introduction of medical drones for specimen transport exemplifies the hospital's commitment to smart healthcare and emergency response systems [9]. Group 4: Performance Metrics and Growth - Since its establishment, the hospital has seen significant increases in outpatient visits, inpatient admissions, and surgical procedures, with outpatient volume growing by 28.39% and surgical volume by 32.69% year-on-year [14]. - The hospital has implemented 181 new projects and filled 19 technical gaps since its opening, demonstrating its role as a regional medical leader [14]. Group 5: Talent Development and Training - The hospital has established a support mechanism involving resident experts and rotating specialists to enhance local medical staff capabilities, focusing on long-term talent cultivation [16][17]. - A total of 93 clinical experts have been dispatched to the hospital, contributing to the development of key medical disciplines and improving overall healthcare quality [17][18].

（来源：千龙网） 这并非个例。2024年，遭前妻视频举报"常年嫖娼并包养情人""通宵达旦赌博"的武汉大学人民医院胰腺 外科主任医师、武汉大学教授汤某某，在被撤职两个月后，以"科主任"身份出现在武汉市第六医院的挂 号系统中，也曾引发关注。 尽管医院称其录用流程"合规"，舆论却仍然紧盯不放，这也说明公众对于医德不会置之不理。现如今， 同样的舆论压力之下，铜仁这家医院表示祖某某"不来了"，短短一天，该坐诊消息便经历了发布、发 酵、撤回全过程。 事情过了一个多月，祖某某就开始公开出诊了，这多少让人有些意外。毕竟，如果处理结果尚未公布， 按道理他就仍处在调查阶段，相关责任与边界并未厘清。这当中是否有权力滥用、利益输送，本身也还 需要调查厘清。 在此情况下，医院贸然以"全国知名专家"的身份对外宣传其坐诊安排，本身就极易引发误解，这样 的"擦边"行为似乎在有意淡化对其调查的严肃性，甚至给人以"风波已过、照常出诊"的错误信号。 在网络上也有声音认为，祖某某生活作风问题只是"私德"，与其医疗专业水平并无关系。 但医疗领域是特殊的。这是因为医生直接介入他人的身体、尊严与生命安全，所以医疗行业对从业者的 要求，从来不只是技术是否精 ...

证券研究报告 2025 年 12 月 21 日 湘财证券研究所 本周医药生物下跌 0.14%，涨跌幅排名位列申万一级行业第 22 位 根据 Wind 数据，本周申万一级行业医药生物下跌 0.14%，涨幅排名位列申 万 31 个一级行业第 22 位。沪深 300 指数下跌 0.28%，医药跑赢沪深 300 指数 0.14 个百分点。申万医药生物二级子行业医疗服务 II 报收 6344.37 点，上涨 0.55%；中药 II 报收 6372.09 点，上涨 0.17%；化学制药Ⅱ报收 13271.69 点，下跌 1.74%；生物制品Ⅱ报收 6234.22 点，下跌 0.67%；医 药商业Ⅱ报收 5257.60 点，上涨 4.94%；医疗器械 II 报收 6373.39 点，上 涨 1.16%。 根据 Wind 数据，从医疗服务板块公司的表现来看，表现居前的公司有： 美年健康（+24.1%）、百花医药（+8.8%）、迪安诊断（+8.1%）、澳洋健康 （+6.4%）、光正眼科（+5.1%）；表现靠后的公司有：南华生物（-6.5%）、 美迪西（-5.2%）、ST 中珠（-4.8%）、博腾股份（-4.7%）、毕得医药（- ...

Core Viewpoint - The article discusses the recent incident involving a child who died after heart surgery at Ningbo Women's and Children's Hospital, highlighting discrepancies in the reported size of the heart defect and the implications for medical intervention [3][4]. Group 1: Incident Overview - The autopsy report indicated that the size of the atrial septal defect (ASD) was 1.0cm x 0.9cm, contrary to the family's claim of 0.3cm, suggesting significant implications for the child's growth and development [3]. - Following the child's death, multiple hospital officials, including the chief surgeon, faced disciplinary actions, although the technical assessment of the medical incident has not yet been released [3][4]. Group 2: Medical Context - Atrial septal defects are common in premature infants, with larger defects typically requiring intervention. The standard for surgical intervention in children is flexible, often depending on the size of the defect and the child's age [4]. - Experts indicate that small atrial septal defects may self-resolve, and diagnosis before six months may not be reliable. Surgical intervention is generally recommended before school age to prevent long-term developmental impacts [4]. Group 3: Treatment Options - Treatment for atrial septal defects can be performed via minimally invasive techniques or open-heart surgery, with the choice depending on the defect's characteristics and the patient's condition [5]. - The materials used for surgical repair include autologous pericardium or specially processed bovine pericardium, while interventional procedures utilize occluders made from nickel-titanium alloy [5]. Group 4: Epidemiological Data - Recent epidemiological studies indicate that the incidence of congenital heart disease in China ranges from 8 to 10 per 1,000 live births, with atrial septal defects accounting for approximately 10% to 15% of these cases [6]. - Based on these statistics, the birth prevalence of atrial septal defects is estimated to be between 0.8 and 1.5 per 1,000 live births [6].